Joanna Bereta

Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators.

Taurine (Tau) is an exceptionally abundant free amino acid in the cytosol of inflammatory cells and especially in neutrophils. Taurine protects cells from self‐destruction during processes that generate oxidants. The major function of Tau in leukocytes is to trap chlorinated oxidants (HOCl). Taurine reacts with HOCl to produce the long‐lived compound taurine chloramine (TauCl). Previously, we have shown that other products of the neutrophil chlorinating system are able to modify functions of macrophages. In this study, we investigated in vitro the influence of TauCl on the generation of inflammatory mediators by activated macrophages. We have found that TauCl inhibited the generation of nitric oxide, prostaglandin E2, tumor necrosis factor α, and interleukin‐6, but TauCl slightly enhanced the release of IL‐1α. The formation of nitrites by interferon‐γ‐activated macrophages was inhibited by TauCl in a dose‐dependent manner. Taurine chloramine also reduced the level of inducible nitric oxide synthase (iNOS) mRNA in macrophages, in a similar concentration‐dependent manner. Although our experiments do not exclude a direct effect of TauCl on enzymatic activity of iNOS, the inhibition of iNOS expression seems to be the major mechanism responsible for suppression of NO formation. Finally, we discuss the biological role of TauCl in vivo. We suggest that at the site of inflammation TauCl works as a specific signaling molecule of activated neutrophils that coordinates the generation of inflammatory mediators in macrophages.

Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators

We previously reported that taurine chloramine (TauCl), a product of activated neutrophils, inhibits the generation of macrophage inflammatory mediators such as nitric oxide (NO), TNF-alpha, and PGE2. Taurine, the most abundant free amino acid in the cytosol of neutrophils, is chlorinated to form TauCl by the halide-dependent myeloperoxidase (MPO) system. Under physiological conditions, TauCl reduces HOCl toxicity. In this study, we investigated the influence of TauCl on generation of oxygen free radicals, cytokines and eicosanoids by activated murine peritoneal neutrophils. We found that TauCl, but not taurine alone, inhibited the production of NO, prostaglandin E2, interleukin-6 and tumor necrosis factor-alpha, in a dose-dependent manner. In contrast, the products of the respiratory burst, as measured by luminol-dependent chemiluminescence (LCL), were reduced by both taurine and TauCl. However, taurine affected LCL at higher concentrations and to a lesser extent than TauCl. The results of these studies suggest that TauCl decreases production of tissue-damaging inflammatory mediators and may regulate the balance between protective, microbicidal and toxic effect of neutrophils.

Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines.

Cytokine‐dependent regulation of tissue inhibitors of metalloproteinases (TIMPs) expression provides an important mechanism for controlling the activity of matrix metalloproteinases. We present data indicating that during inflammatory processes TIMP‐1 and TIMP‐3 may be involved in the proteolytic remodeling of subendothelial basement membrane of the brain microvascular system, a key step during leukocyte migration into the brain perivascular tissue. In brain endothelial cells the expression of TIMP‐1 is dramatically up‐regulated by major proinflammatory cytokines, with the combination of interleukin‐1β (IL‐1β) and tumor necrosis factor‐α (TNFα) exhibiting the strongest synergistic stimulation. Simultaneously, IL‐1β/TNFα almost completely blocks TIMP‐3 expression. Both synergistic effects are dose‐dependent within the concentration range 0.05–5 ng/ml of both cytokines and correlate with the expression of inducible nitric oxide synthase, an endothelial cell activation marker. Down‐regulation of TIMP‐3 expression is also detected in astrocytes treated with TNFα or IFN‐γ, whereas oncostatin M as well as TNFα up‐regulate TIMP‐1 mRNA level. We propose that the cytokine‐modified balance between TIMP‐1 and TIMP‐3 expression provides a potential mechanism involved in the regulation of microvascular basement membrane proteolysis.

Inactivation of membrane tumor necrosis factor alpha by gingipains from Porphyromonas gingivalis.

ABSTRACT Gingipains are cysteine proteinases produced by Porphyromonas gingivalis, a major causative bacterium of adult periodontitis. They consist of arginine-specific (HRgpA and RgpB) and lysine-specific (Kgp) proteinases. Gingipains strongly affect the host defense system by degrading some cytokines, components of the complement system, and several immune cell receptors. In an in vitro model, gingipains were shown to degrade soluble tumor necrosis factor alpha (TNF-α). However, since membrane TNF-α shows strong biological activity, especially in local inflammatory lesions, it was worth investigating whether gingipains might also destroy membrane TNF-α and limit its biological activities. To avoid a possible influence of gingipains on ADAM17, the secretase of TNF-α, the majority of experiments were performed using ADAM17−/− fibroblasts stably transfected with cDNA of human pro-TNF-α (ADAM17−/− TNF+). Arginine-specific gingipains (Rgps) strongly diminished the level of TNF-α on the cell surface as measured by flow cytometry, and this process was not accompanied by an increased concentration of soluble TNF-α in the culture medium. Degradation of membrane TNF-α by Rgps correlated with a strong decrease in TNF-α-mediated biological activities of ADAM17−/− TNF+ cells. First, the activation state of transcription factor NF-κB was suppressed; second, the cells were no longer able to induce apoptosis in HL-60 cells. Kgp was also able to cleave membrane TNF-α, but its effect was much weaker than that of Rgps. Gingipains also limited the binding of native TNF-α to the target cells. Thus, gingipains are able not only to cleave soluble TNF-α but also to destroy the membrane form of the cytokine, which may additionally dysregulate the cytokine network.

Stimulatory effect of ouabain on VCAM-1 and iNOS expression in murine endothelial cells: involvement of NF-κB

Endothelial cells play a pivotal role in the development of atherosclerosis. An ‘activated’ phenotype of these cells is manifested by signal transduction‐dependent expression of genes encoding cytokines, pro‐ and anticoagulant factors, and cell adhesion molecules. In the current study we examined the effect of ouabain, an inhibitor of Na+/K+‐ATPase, on the process of endothelial cell activation. We demonstrated that ouabain was able to stimulate VCAM‐1 expression and potentiate the effect of IFN‐γ on this process. Moreover, ouabain provided a complementary signal for either TNF or IFN‐γ in inducing iNOS expression. Our data also show, for the first time, that inhibition of Na+/K+‐ATPase led to activation of the transcription factor, NF‐κB, which may provide an explanation for the effects of ouabain on endothelial cells.

Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts

ADAM17 (a disintegrin and metalloprotease)-deficient murine fibroblasts stably transfected with proTNF cDNA release significant amounts of biologically active soluble TNF. The enzyme responsible for this activity is a membrane protein that hydrolyzes the peptide bond Ala(76):Val(77) within proTNF. Its activity is inhibited by 1,10-phenantroline and GM6001, insusceptible to TIMP-2 (tissue inhibitor of metalloproteinases-2), and stimulated by ionomycin. These characteristics match ADAM10. The moderate silencing of ADAM10 by shRNA resulted in a significant inhibition of TNF shedding. There was no correlation between the level of ADAM10 expression and the presence of active ADAM17. Our results indicate that ADAM10 may function as the TNF sheddase in cells which lack ADAM17 activity.

Apoptins: selective anticancer agents

Therapies that selectively target cancer cells for death have been the center of intense research recently. One potential therapy may involve apoptin proteins, which are able to induce apoptosis in cancer cells leaving normal cells unharmed. Apoptin was originally discovered in the Chicken anemia virus (CAV); however, human gyroviruses (HGyV) have recently been found that also harbor apoptin-like proteins. Although the cancer cell specific activity of these apoptins appears to be well conserved, the precise functions and mechanisms of action are yet to be fully elucidated. Strategies for both delivering apoptin to treat tumors and disseminating the protein inside the tumor body are now being developed, and have shown promise in preclinical animal studies.

Different preparations of natural and recombinant human interleukin-6 (ifn-β2, bsf-2) similarly stimulate acute phase protein synthesis and uptake of α-aminoisobutyric acid by cultured rat hepatocytes

1. Rat hepatocytes were cultured for 2 days in Williams E medium containing 1 microM insulin and dexamethasone. 2. Production of five plasma proteins was determined by electroimmunoassay in the media, and amino acid uptake was measured by [alpha-14C]aminoisobutyric acid accumulation in hepatocytes. 3. Supernatants from rat peritoneal macrophages and IL-6/IFN-beta 2/BSF-2 obtained from four different laboratories similarly stimulated synthesis of fibrinogen, alpha 1-cysteine proteinase inhibitor and alpha 2-macroglobulin, as well as [14C]-accumulation in cultured hepatocytes. 4. It is concluded that IL-6 is the principal hepatocyte stimulating factor responsible for typical features of the acute phase response of liver cells.

Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles

Expression of costimulatory molecules by recombinant poxviruses is a promising strategy for enhancing therapeutic vaccines. CD40–CD40L interactions are critical for conditioning dendritic cells (DC) and priming T- and B-cell immunity. We constructed a vaccinia virus expressing murine CD40L (rV-CD40L) and studied its immunomodulatory properties in vitro. Direct DC infection with control vaccinia or psoralen/UV-inactivated rV-CD40L stimulated high levels of interleukin 12 (IL-12) release. However, replication-competent rV-CD40L did not stimulate IL-12 under similar conditions. We observed a high level of CD40L protein on purified viral particles and demonstrated that induction of IL-12 by nonreplicating rV-CD40L was blocked by anti-CD40 antibodies suggesting that functional CD40L on viral particles contributed to alterations in IL-12 synthesis.Since cross-presentation of tumor-associated antigens by DC is augmented by viral infection of tumor cells, we infected MC38 murine colon carcinoma cells with rV-CD40L. Infected cells stimulated IL-12 secretion by DC and proliferation of B cells and DX5+ (NK/NKT) cells through direct CD40–CD40L interaction. A subpopulation of NKT cells expressing CD40 (NK1.1+, CD3lo) appeared to be a major effector population responding to MC38/rV-CD40L. These results highlight the complex immune regulatory effects of rV-CD40L defined by the cumulative effects of CD40L expression, presence of CD40L protein in viral particles, and the replication potential of the virus.

Effects of elastase and cathepsin G on the levels of membrane and soluble TNFα

Abstract Neutrophil elastase (NE) and cathepsin G (CG), the proteolytic enzymes localized in azurophil granules of neutrophils (PMN), are involved in PMN responses to various stimuli. When released at sites of inflammation, they participate in the degradation of numerous proteins involved in the regulation of the immune response. In this study, we employed ADAM17-/- fibroblasts stably transfected with cDNA of human pro-tumor necrosis factor α (proTNFα) (ADAM17-/-TNF+) to investigate the effects of NE and CG on shedding and degradation of TNFα. Both NE and CG were found to diminish the level of membrane TNFα (mTNFα) as measured by flow cytometry. This process was accompanied by the accumulation of biologically active soluble TNFα (sTNFα) in the culture medium, as determined by an increase in both the cytotoxic activity of TNFα and its ability to serve as a co-stimulator in the induction of inducible nitric oxide synthase (iNOS). However, in contrast to CG, NE at high concentrations was able to degrade sTNFα released from the cell surface. Using soluble recombinant human TNFα, we identified Val93-Ala94 and Val117-Glu118 as the NE cleavage sites within the sTNFα molecule. Taken together, the ability of NE and CG to modulate levels of membrane and soluble forms of TNFα may contribute to the proinflammatory activity of neutrophils.